#United States #Capital Markets #Jersey City #WallachBeth #Tenon Medical

WallachBeth Capital Closes $4.3 Million Deal for Tenon Medical

On March 12, 2026, WallachBeth Capital LLC, recognized for its expertise in capital markets, announced a successful closing of a private placement for Tenon Medical, Inc. With a focus on enhancing healthcare innovation, this agreement raised a substantial $4.3 million through senior original issue discount convertible notes. The funding aims to bolster Tenon Medical's efforts in commercial and product expansion as well as clinical initiatives.

Overview of the Offering

The private placement, featuring a 20% original issue discount note framework, is structured with an aggregate principal amount of $4.3 million. These notes come with a maturity date set for September 11, 2026. A key feature of this offering is the conversion option that becomes available six months post-issuance, allowing investors to convert into shares of common stock at 80% of the volume-weighted average price (VWAP) based on trading activity before the conversion takes place.

WallachBeth Capital acted as the placement agent for this transaction, facilitating connections between Tenon Medical and a selection of institutional and high-net-worth investors. This strategic partnership is expected to fulfill both parties' objectives and enhance Tenon Medical's financial resilience.

Utilization of Proceeds

The funds raised from this transaction are earmarked for several vital initiatives: commercial expansion, product development, clinical studies, and general working capital needs. This diversified allocation underscores Tenon’s commitment to advancing its operational goals and driving innovation within the medical sector.

Legal Framework and Compliance

The issuance of these notes has been closely monitored within the legal framework governing securities. Legal counsel for Tenon included Sichenzia Ross Ference Carmel LLP, while counsel for WallachBeth Capital was provided by Sheppard, Mullin, Richter and Hampton LLP. It is essential to note that the notes and the corresponding shares have not been registered under the Securities Act of 1933 or any state laws, ensuring adherence to regulatory requirements. Consequently, these securities cannot be offered or sold in the United States until appropriate registration or exemption is established.

Forward-Looking Statements

In the press announcement, WallachBeth included forward-looking statements, indicating optimism about Tenon Medical's future performance based on its current operational outlook. Such statements inherently possess risk factors, leading to possible variations from expectations. Investors are encouraged to refer to Tenon's annual report on Form 10-K and other filed documents for details on risks that may impact performance.

As Tenon Medical prepares to utilize these proceeds for significant growth initiatives, this partnership with WallachBeth Capital could mark a pivotal point in the company's trajectory, potentially leading to enhanced product offerings and advancements in medical technology.

About WallachBeth Capital

WallachBeth Capital is a prominent provider of comprehensive capital markets services tailored to the healthcare sector, connecting clients with leading institutional entities. The firm excels in various areas including initial public offerings, follow-on offerings, and private transactions, representing a critical player in the financial landscape for healthcare innovation.

In conclusion, the successful closing of this $4.3 million offering positions Tenon Medical for growth while reinforcing WallachBeth Capital’s role as a significant partner in healthcare investment. Stakeholders and analysts will be closely monitoring the developments that arise from this strategic initiative in the coming months.

For further information, visit WallachBeth Capital.